无监督分类识别撒哈拉以南非洲脓毒症宿主反应的主要病理生物学特征
研究在乌干达两个前瞻性成人脓毒症队列(发现队列恩德培城市n=242,验证队列托罗罗农村n=253)中,对173种可溶性蛋白进行无监督聚类,识别出两种病理生物学特征USS-1和USS-2,并由五蛋白分类器(AUC 0.97)在验证队列中重现。USS-2对应更严重的临床表型,与HIV及相关免疫抑制、重症结核和30天死亡风险增加相关,并与高收入国家识别的高炎症和反应性脓毒症表型有显著生物学重叠。作者认为需要全球包容性研究来定义可推广且情境特异的脓毒症病理生物学机制,以改善精准医学治疗策略的可及性。
要点
- 在乌干达两个成人脓毒症队列中,无监督聚类识别出USS-1和USS-2两种宿主反应特征,由髓系细胞和炎症小体激活、T细胞共刺激和耗竭、内皮屏障功能障碍相关蛋白区分。
- 五蛋白分类器(AUC 0.97)在验证队列中重现两种特征,生物学谱相似。
- USS-2在发现和验证队列中均对应更严重临床表型,与HIV及相关免疫抑制、重症结核和30天死亡风险增加相关。
- USS-2与高收入国家识别的高炎症和反应性脓毒症表型存在显著生物学重叠。
适用人群与场景
- 乌干达两个前瞻性成人脓毒症住院队列:发现队列为恩德培城市患者(n=242),验证队列为托罗罗农村患者(n=253)。
- 脓毒症定义为严重感染且快速脓毒症相关器官衰竭评估(qSOFA)评分≥1。
诊断标准与关键阈值
- 脓毒症纳入标准:严重感染且qSOFA评分≥1。
研究设计与关键结果
- 研究类型为对两个前瞻性成人脓毒症队列的分析;发现队列n=242(恩德培城市),验证队列n=253(托罗罗农村),共分析173种反映宿主对严重感染反应关键域的可溶性蛋白。
- 在发现队列中通过无监督聚类识别出两种特征(USS-1和USS-2),由髓系细胞和炎症小体激活、T细胞共刺激和耗竭、内皮屏障功能障碍相关蛋白的表达区分。
- 随机森林衍生的五蛋白分类器在验证队列中重现两种特征,受试者工作特征曲线下面积(AUC)为0.97,生物学谱相似。
- 在两个队列中,USS-2均对应更严重的临床表型,与HIV及相关免疫抑制、重症结核和30天死亡风险增加相关。
- USS-2与高收入国家识别的高炎症和反应性脓毒症表型之间存在显著生物学重叠。
证据类型、等级与局限
- 证据类型:对两个前瞻性成人脓毒症队列的分析(发现队列n=242,验证队列n=253)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需要全球包容性研究来定义可推广且情境特异的脓毒症病理生物学机制,目标是改善精准医学治疗策略的可及性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: The global burden of sepsis is concentrated in sub-Saharan Africa, where inciting pathogens are diverse and HIV coinfection is a major driver of poor outcomes. Biological heterogeneity inherent to sepsis in this setting is poorly defined. Objectives: To identify dominant pathobiological signatures of sepsis in sub-Saharan Africa and their relationship to clinical phenotypes, patient outcomes, and biological classifications of sepsis identified in high-income countries (HICs). Methods: We analyzed two prospective cohorts of adults hospitalized with sepsis (severe infection with quick Sepsis-related Organ Failure Assessment score ⩾1) at disparate settings in Uganda (discovery cohort [Entebbe, urban], n = 242; validation cohort [Tororo, rural], n = 253). To identify pathobiological signatures in the discovery cohort, we applied unsupervised clustering to 173 soluble proteins reflecting key domains of the host response to severe infection. A random forest-derived classifier was used to predict signature assignment in the validation cohort. Measurements and Main Results: Two signatures (Uganda Sepsis Signature [USS]-1 and USS-2) were identified in the discovery cohort, distinguished by expression of proteins involved in myeloid cell and inflammasome activation, T-cell costimulation and exhaustion, and endothelial barrier dysfunction. A five-protein classifier (area under the receiver operating characteristic curve, 0.97) reproduced two signatures in the validation cohort with similar biological profiles. In both cohorts, USS-2 mapped to a more severe clinical phenotype associated with HIV and related immunosuppression, severe tuberculosis, and increased risk of 30-day mortality. Substantial biological overlap was observed between USS-2 and hyperinflammatory and reactive sepsis phenotypes identified in HICs. Conclusions: We identified prognostically enriched pathobiological signatures among patients with sepsis with diverse infections and high HIV prevalence in Uganda. Globally inclusive investigations are needed to define generalizable and context-specific mechanisms of sepsis pathobiology, with the goal of improving access to precision medicine treatment strategies.
参考来源
- Cummings MJ, Lutwama JJ, Owor N, et al. Unsupervised Classification of the Host Response Identifies Dominant Pathobiological Signatures of Sepsis in Sub-Saharan Africa. Am J Respir Crit Care Med. 2025. PMID: 39514831. doi:10.1164/rccm.202407-1394OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。